Biofortuna
Biofortuna to Further Commercialize Genotyping Assays With £1.6M Financing
The company said that the funds will allow it to take its ReadyPlex rapid blood group genotyping assays into clinical trials and commercialization.
In Brief This Week: Foundation Medicine; Exact Sciences; Eurofins Genomics; and More
A brief recap of Genetics/Genomics news the week of Oct 7, 2016: SEC, Exact Sciences, Eurofins MWG Operon, Almac Group, California Blood organizations, Stat-Diagnostica, and Biofortuna
Biofortuna Closes $2.2M Funding Round
The new investment will support an expanding contract business as well as in-house MDx development.
NEW YORK (GenomeWeb) — Citing increased demand from companies outsourcing freeze-drying of diagnostic kits, molecular diagnostics firm Biofortuna has expanded its PCR reagent lyophilization production service.
Feb 25, 2014
Biofortuna Gets FDA OK for Freeze Dried HLA Kits
Aug 19, 2013
Biofortuna Nabs $2.0M Investment
Apr 25, 2012
Biofortuna, Abbott Extend Distribution Deal
Apr 21, 2011
Feb 4, 2011
UK MDx Shop Biofortuna Raises $1.6M, Feb 4, 2011
Sep 30, 2010
Sep 30, 2010
Sep 16, 2010
May 26, 2010
UK MDx Shop Biofortuna Raises $1.6M, May 26, 2010
Nov 17, 2009